Repligen Corp (RGEN)

254.92 +2.33  +0.92% NASDAQ Aug 5, 16:08 254.92 --  -- After-Hours: 16:08 USD
View Full Chart
Price Chart
View All RGEN News

News

View All Events

Events

Date Type Description
11/05/2021 Earnings Results Q3 2021 Earnings Results
11/05/2021 08:30 EST Earnings Calls Q3 2021 Earnings Call
07/27/2021 Earnings Results Q2 2021 Earnings Results
07/27/2021 08:30 EST Earnings Calls Q2 2021 Earnings Call
05/13/2021 12:00 EST AGM 2020 Annual General Meeting
05/04/2021 Earnings Results Q1 2021 Earnings Results
05/04/2021 08:30 EST Earnings Calls Q1 2021 Earnings Call
02/24/2021 Earnings Results Q4 2020 Earnings Results
02/24/2021 08:30 EST Earnings Calls Q4 2020 Earnings Call
11/05/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in the United States.
  • URL: https://www.repligen.com
  • Investor Relations URL: https://www.repligen.com/company/investors
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Medical Instruments & Supplies
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Nov. 05, 2021
  • Last Earnings Release: Jul. 27, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
DYN1628 Dynamic Power American Growth Series IP (USD) 3.82%
XMMO Invesco S&P MidCap Momentum ETF 3.14%
AOFCX Alger Small Cap Focus C 2.88%
CCASX Conestoga Small Cap Investors 2.83%
DIGGX Invesco Discovery R5 2.03%
IJK iShares S&P Mid-Cap 400 Growth ETF 1.15%
IBB iShares Biotechnology ETF 0.95%
TQAAX T. Rowe Price QM US Small-Cap Gr Eq Adv 0.90%
FKBSX Federated Hermes Kaufmann Small Cap B 0.78%
IJH iShares Core S&P Mid-Cap ETF 0.54%
SPMD SPDR® Portfolio S&P 400 Mid Cap ETF 0.52%
SCHA Schwab US Small-Cap ETF™ 0.29%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.